[ET Net News Agency, 27 September 2024] IMMUNEONCO-B (01541) rose 20.2% to HK$6.01,
breaking above the 20-D SMA of HK$5.563.
It hits an intra-day high of HK$6.05, and an intra-day low of HK$5.09. The total shares
traded was 5.21 million, with a value of HK$28.81m. The active buy/sell ratio is 64:36,
with net buying turnover of HK$7.62m. FUTU SEC INT'L accounts for greatest net responsive
buying turnover of HK$322,614, with volume weighted average price of HK$5.582. J.P. MORGAN
BRO (HK) accounts for greatest net responsive selling turnover of HK$467,442, with volume
weighted average price of HK$5.628. The stock has risen a combined 23.9% over the past 2
consecutive trading days.

Basic Information
=================

---------------------------------
Nominal 6.010 % Chg +20.20%
High 6.050 Low 5.090
Shares Tr 5.21m Turnover 28.81m
10-D SMA 5.331 %H.V 262.227
20-D SMA 5.563 VWAP 5.534
50-D SMA 8.936 RSI14 46.370
---------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 64:36, with net buying
turnover of HK$7.62m, rising a combined 23.9% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 6.01 +20.20
GENSCRIPT BIO (01548) 12.18 +7.79
INNOVENT BIO (01801) 45.70 +2.01
JXR (01951) 3.00 +5.63
WUXI XDC (02268) 21.75 +6.36
WUXI BIO (02269) 14.94 +7.79
BEIGENE (06160) 131.20 +2.18
SKB BIO-B (06990) 163.50 -3.43
ZAI LAB (09688) 17.54 +8.00
AKESO (09926) 66.05 +3.28
---------------------------------------------
(ed)